LOS ANGELES, CA / ACCESSWIRE / September 20, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Depomed, Inc. ("Depomed" or the "Company") (DEPO) for possible violations of federal securities laws from February 26, 2015 through August 7, 2017, inclusive (the "Class Period"). Investors who purchased or otherwise acquired Depomed shares during the Class Period should contact the firm prior to the October 17, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at email@example.com.
No class has been certified in the above action yet. Until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.
According to the Complaint, throughout the Class Period, Depomed made false and/or misleading statements, and/or failed to disclose: that the Company engaged in questionable practices in connection with the sales and marketing of its opioid products; that this conduct would likely subject Depomed to heightened legal and regulatory scrutiny; and that as a result of the above, the Company's public statements were materially false and misleading at all relevant times.
On August 7, 2017, Depomed revealed that it "recently received a request for information from the ranking minority member of the United States Senate Committee on Homeland Security and Governmental Affairs related to the promotion of opioids" and that Depomed had also received "subpoenas related to opioid sales and marketing from the Office of the Attorney General of Maryland and the United States Department of Justice." When this information was released, shares of Depomed decreased in value, which caused investors harm according to the Complaint.
Lundin Law PC was established by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders' rights.
This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and rules of ethics.
SOURCE: Lundin Law PC